Novonesis (Novozymes A/S)
Transactions under Novonesis’ share buyback program
Transactions under Novonesis’ share buyback program
Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated 1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025.
Please read the full announcement in PDF.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ONWARD Medical NV1.7.2025 07:30:00 CEST | Press release
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application
Sodexo SA1.7.2025 07:00:00 CEST | Press release
Sodexo Q3 Fiscal 2025 revenues in line with expectations
dsm-firmenich1.7.2025 07:00:00 CEST | Press release
dsm-firmenich announces redemption of €750 million hybrid bond
dsm-firmenich1.7.2025 07:00:00 CEST | Press release
Weekly progress on share repurchase program to cover share plans and reduce capital
Atico Mining Corporation30.6.2025 22:29:54 CEST | Press release
Atico Mining Announces Execution of Loan Amendment with Trafigura to Restructure Outstanding Credit Facility
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom